Search results
H. Michael Shepard (born 1949) is an American cancer researcher who was awarded the 2007 Harvard Medical School Warren Alpert Foundation Prize and the 2019 Lasker Clinical research award, which he shared with Dennis Slamon and Axel Ullrich for their development of Herceptin
Mar 15, 2024 · In this World View, H. Michael Shepard describes his personal story behind the discovery of trastuzumab, 25 years since its FDA approval for HER2-overexpressing breast cancers.
Michael Shepard, MD specializes in orthopaedic surgery. He renders the most comprehensive care for knee, elbow and shoulder injuries. Dr. Shepard uses the latest medical technology with the state of art medical facility to provide his patients the best possible outcome.
The 2019 Lasker~DeBakey Clinical Medical Research Award honors three scientists—H. Michael Shepard, Dennis J. Slamon, and Axel Ullrich —who invented Herceptin, the first monoclonal antibody that blocks a cancer-causing protein, and developed it into a life-saving therapy for women with breast cancer. The innovation reduces the risk of ...
Michael Sheard (born Michael Lawson Perkins; 18 June 1938 – 31 August 2005) was a Scottish character actor who featured in many films and television programmes, and was known for playing villains.
Nov 30, 2021 · Dr. Shepard, an innovator in the field of biotechnology and pioneer in cancer research, won the 2019 Lasker-DeBakey Clinical Medical Research Award with colleagues Dr. Dennis J. Slamon and Axel...
Sep 24, 2019 · Dr. H. Michael Shepard and his team have identified a critical breast cancer biomarker and developed the drug Herceptin, which can treat more than just breast cancer.
